Olson Eric R

CIK 00016781491 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001678149

Recent Transactions

36 trades

Sale
Syros Pharmaceuticals, Inc.
Common Stock
2023-07-17$3.50/sh−689→ 6,661 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-04-03$2.58/sh−623→ 7,350 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-03-31−2,000→ 6,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-03-31+2,000→ 7,973 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-02-16+35,000→ 35,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-10-06+34,000→ 34,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-10-06+44,500→ 44,500 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2022-04-01$1.12/sh−27,266→ 59,734 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+200,000→ 200,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-02-15+100,000→ 100,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+80,000→ 80,000 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2022-01-05$3.47/sh−2,208→ 0 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2021-07-01$5.55/sh−1,164→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-03-15−3,628→ 90,697 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2021-03-15$1.01/sh+3,628→ 3,628 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2021-03-15$9.47/sh−3,628→ 0 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-02-17+94,000→ 94,000 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2020-08-18$13.00/sh−10,787→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2020-08-18$1.01/sh+10,787→ 10,787 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-08-18−10,787→ 94,325 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2020-08-17$1.01/sh+4,963→ 4,963 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-08-17−4,963→ 105,112 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2020-08-17$13.00/sh−4,963→ 0 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2020-07-07$11.72/sh−1,753→ 0 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2020-02-18$7.38/sh−1,446→ 0 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-02-13+94,000→ 94,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2019-02-12+87,000→ 87,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2019-02-12+75,000→ 75,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-16+75,000→ 75,000 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2017-08-07$23.59/sh−2,500→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-08-07+2,500→ 110,075 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2017-08-07$1.01/sh+2,500→ 2,500 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2017-07-25$21.85/sh−12,500→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2017-07-25$1.01/sh+12,500→ 12,500 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-07-25+12,500→ 25,025 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-02-10+63,500→ 63,500 total

Companies

Syros Pharmaceuticals, Inc.
Chief Scientific Officer

Recent Filings

Address

C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE, SUITE 300

CAMBRIDGE, MA, 02139

View on SEC.gov